Page last updated: 2024-08-21

mevalonolactone and aminoimidazole carboxamide

mevalonolactone has been researched along with aminoimidazole carboxamide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Etemadmoghadam, D; Fraser, SA; Kandane, RK; Kanellis, J; Kemp, BE; Levidiotis, V; Mount, PF; Power, DA	1

Other Studies

1 other study(ies) available for mevalonolactone and aminoimidazole carboxamide

Article	Year
Activators of the energy sensing kinase AMPK inhibit random cell movement and chemotaxis in U937 cells. Immunology and cell biology, 2006, Volume: 84, Issue:1 Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinase Kinases; Cell Movement; Chemokine CCL2; Chemokine CXCL12; Chemokines, CXC; Chemotaxis; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Activation; Enzyme Activators; Humans; Lovastatin; Mevalonic Acid; Protein Kinases; rho GTP-Binding Proteins; Ribonucleotides; U937 Cells	2006

Article

Year

Activators of the energy sensing kinase AMPK inhibit random cell movement and chemotaxis in U937 cells.

Immunology and cell biology, 2006, Volume: 84, Issue:1

Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinase Kinases; Cell Movement; Chemokine CCL2; Chemokine CXCL12; Chemokines, CXC; Chemotaxis; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Activation; Enzyme Activators; Humans; Lovastatin; Mevalonic Acid; Protein Kinases; rho GTP-Binding Proteins; Ribonucleotides; U937 Cells

2006